Artivion (AORT) Divestments (2016 - 2017)

Artivion (AORT) reported Divestments of $740000.0 for Q1 2017, down 96.26% on a YoY basis from $19.8 million in Q1 2016, and down 96.26% quarter-over-quarter from $19.8 million in Q1 2016.

Artivion (AORT) Divestments (2016 - 2017) Analysis & Trends

Artivion has reported Divestments for 2 years, with the latest figure at $740000.0 in Q1 2017.

  • For the quarter ending Q1 2017, Divestments fell 96.26% year-over-year to $740000.0; the trailing twelve-month figure through Dec 2017 stood at $740000.0 (down 96.26% YoY), and the FY2017 full-year result was $740000.0, down 96.26% from the prior year.
  • Divestments for Q1 2017 stood at $740000.0, down from $19.8 million in the prior quarter.
  • The five-year high for Divestments was $19.8 million in Q1 2016, with the low at $740000.0 in Q1 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 9.37 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -
10 Artivion 1.02 Bn 961.48 Mn 75.45 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2017 740,000.00
Mar 31, 2016 19.80 Mn